These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 18678300

  • 21. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
    Bays HE, Tighe AP, Sadovsky R, Davidson MH.
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
    [Abstract] [Full Text] [Related]

  • 22. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Mar; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 23. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.
    Am J Cardiol; 2008 Feb 15; 101(4):486-9. PubMed ID: 18312763
    [Abstract] [Full Text] [Related]

  • 24. Prescription omega-3 fatty acid as an adjunct to fenofibrate therapy in hypertriglyceridemic subjects.
    Roth EM, Bays HE, Forker AD, Maki KC, Carter R, Doyle RT, Stein EA.
    J Cardiovasc Pharmacol; 2009 Sep 15; 54(3):196-203. PubMed ID: 19597368
    [Abstract] [Full Text] [Related]

  • 25. Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women.
    Fak AS, Erenus M, Tezcan H, Caymaz O, Atagündüz P, Oktay S, Oktay A.
    Eur Heart J; 2000 Feb 15; 21(3):190-7. PubMed ID: 10639300
    [Abstract] [Full Text] [Related]

  • 26. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
    Knopp RH, Tsunehara C, Retzlaff BM, Fish B, Nguyen H, Anderson S, Nguyen T.
    Metabolism; 2006 Dec 15; 55(12):1697-703. PubMed ID: 17142146
    [Abstract] [Full Text] [Related]

  • 27. Effect of combining psyllium fiber with simvastatin in lowering cholesterol.
    Moreyra AE, Wilson AC, Koraym A.
    Arch Intern Med; 2005 May 23; 165(10):1161-6. PubMed ID: 15911730
    [Abstract] [Full Text] [Related]

  • 28. Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2011 Jul 01; 108(1):40-6. PubMed ID: 21565322
    [Abstract] [Full Text] [Related]

  • 29. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F, Montant PF, Marcovitch O, Blaimont M, de Meester A, Descamps OS.
    Eur J Clin Invest; 2007 May 01; 37(5):357-63. PubMed ID: 17461981
    [Abstract] [Full Text] [Related]

  • 30. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Karalis DG, Ishisaka DY, Luo D, Ntanios F, Wun CC.
    Am J Cardiol; 2007 Aug 01; 100(3):445-9. PubMed ID: 17659926
    [Abstract] [Full Text] [Related]

  • 31. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR, Brown BG, Fazio S, Polis A, Tomassini JE, Tershakovec AM.
    J Am Coll Cardiol; 2008 Apr 22; 51(16):1564-72. PubMed ID: 18420099
    [Abstract] [Full Text] [Related]

  • 32. Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C.
    Miller M, Dobs A, Yuan Z, Battisti WP, Borisute H, Palmisano J.
    Curr Med Res Opin; 2004 Jul 22; 20(7):1087-94. PubMed ID: 15265253
    [Abstract] [Full Text] [Related]

  • 33. Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.
    Maki KC, Carson ML, Miller MP, Anderson WH, Turowski M, Reeves MS, Kaden V, Dicklin MR.
    Eur J Clin Nutr; 2009 Aug 22; 63(8):1001-7. PubMed ID: 19209184
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.
    Goldberg AC, Bays HE, Ballantyne CM, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC.
    Am J Cardiol; 2009 Feb 15; 103(4):515-22. PubMed ID: 19195513
    [Abstract] [Full Text] [Related]

  • 35. Simvastatin treatment on postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia.
    Sheu WH, Jeng CY, Lee WJ, Lin SY, Pei D, Chen YT.
    Metabolism; 2001 Mar 15; 50(3):355-9. PubMed ID: 11230791
    [Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of Omacor in severe hypertriglyceridemia.
    Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K.
    J Cardiovasc Risk; 1997 Mar 15; 4(5-6):385-91. PubMed ID: 9865671
    [Abstract] [Full Text] [Related]

  • 37. Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters.
    McKenney JM, Swearingen D, Di Spirito M, Doyle R, Pantaleon C, Kling D, Shalwitz RA.
    J Clin Pharmacol; 2006 Jul 15; 46(7):785-91. PubMed ID: 16809804
    [Abstract] [Full Text] [Related]

  • 38. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 15; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 39. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct 15; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 40. Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with Frederickson type IV dyslipidemia phenotype.
    Bermúdez-Pirela V, Souki A, Cano-Ponce C, Bermúdez-Arias F, Mengual-Moreno E, Leal-Gonzalez E, Lemus-Antepaz M, de Bravo MC, de Díaz AA, de Pirela NL, Cano-Peñaloza R, Puche-Medina G, Arraiz N, Reyna-Villazmil N, Contreras F, Israili ZH, Valasco M.
    Am J Ther; 2007 Oct 15; 14(2):213-20. PubMed ID: 17414592
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.